|
Basic Characteristics of Mutations
|
|
Mutation Site
|
E484K |
|
Mutation Site Sentence
|
Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
S |
|
Standardized Encoding Gene
|
S
|
|
Genotype/Subtype
|
B.1.243.1 |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
COVID-19
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
- |
|
Location
|
USA |
|
Literature Information
|
|
PMID
|
34545803
|
|
Title
|
Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA
|
|
Author
|
Skidmore PT,Kaelin EA,Holland LA,Maqsood R,Wu LI,Mellor NJ,Blain JM,Harris V,LaBaer J,Murugan V,Lim ES
|
|
Journal
|
Emerging infectious diseases
|
|
Journal Info
|
2021 Oct;27(10):2718-2720
|
|
Abstract
|
Genomic surveillance can provide early insights into new circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. While conducting genomic surveillance (1,663 cases) from December 2020-April 2021 in Arizona, USA, we detected an emergent E484K-harboring variant, B.1.243.1. This finding demonstrates the importance of real-time SARS-CoV-2 surveillance to better inform public health responses.
|
|
Sequence Data
|
-
|